arrow
B

Barbara Meissner

prszt
H指数:37
被引数:8,181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma

LySeqST:一种用于弥漫性大B细胞淋巴瘤稳健基因组分类的靶向测序检测方法

2026-04-170
OAAI
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patients

德国年轻成人急性白血病自体造血干细胞移植后的生存趋势:与更年轻和更年长患者的比较

2026-04-120
PREAI
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology

在高MYC/BCL2易位的弥漫大B细胞淋巴瘤中,进行剂量调整的EPOCH-R方案的群体推广,该淋巴瘤具有DLBCL形态。

2025-10-170
OAAI
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

高级别B细胞淋巴瘤,非其他特指类型:一项LLMPP研究。

2025-07-210
OAAI
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma

体细胞IRF4突变和胸腺趋向性在原发性纵隔大B细胞淋巴瘤中的作用

Blood
IF23.1
2025-06-240
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy

一种基于遗传学的晚期滤泡性淋巴瘤新型分类法,可识别接受 bendamustine-rituximab 免疫化疗后的预后亚组

BLOOD
IF23.1
2024-11-050
PRE
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
2024-08-170
OAAI
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
2020-02-2455
OAAI
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
2019-07-010
PRE
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
2019-04-01216
OAAI
High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology
2018-10-2278
OAAI
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
2018-10-01123
OAAI
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management
2018-03-0162
OAAI